Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 -0.88%63 PS Ratio is 0.19 as of Jul. 16, 2026, which is 42% below its 10-year median of 0.33. GuruFocus rates TSE:3353 with a GF Score™ of 63/100 and a GF Value™ of 円3,535.59 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 551 Conglomerates companies, Medical Ikkou Group Co ranks better than 87.84% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Medical Ikkou Group Co's share price is 円2816.00.
Medical Ikkou Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was 円14,605.42. Hence, Medical Ikkou Group Co's PS Ratio for today is 0.19.
Good Sign:
Medical Ikkou Group Co Ltd stock PS Ratio (=0.19) is close to 1-year low of 0.18.
The historical rank and industry rank for Medical Ikkou Group Co's PS Ratio or its related term are showing as below:
TSE:3353'
s PS Ratio Range Over the Past 10 Years
Min: 0.16 Med: 0.33 Max: 1.03
Current: 0.19
During the past 13 years, Medical Ikkou Group Co's highest PS Ratio was 1.03. The lowest was 0.16. And the median was 0.33.
TSE:3353's PS Ratio is ranked better than 87.84% of 551
companies
in the Conglomerates industry
Industry Median: 0.92
vs TSE:3353: 0.19
During the past 12 months, the average Revenue per Share Growth Rate of Medical Ikkou Group Co was 13.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 17.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.00% per year.
During the past 13 years, Medical Ikkou Group Co's highest 3-Year average Revenue per Share Growth Rate was 17.40% per year. The lowest was -14.40% per year. And the median was 5.40% per year.
Back to Basics: PS Ratio
Medical Ikkou Group Co (TSE:3353) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Medical Ikkou Group Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co PS Ratio vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Medical Ikkou Group Co's Share Price of today is 円2816.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Ikkou Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2026 was 円14,605.42.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Medical Ikkou Group Co (TSE:3353) has a PS Ratio of 0.19 as of Jul. 16, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Medical Ikkou Group Co and its competitors. This is 42% below median its historical median of 0.33. Over the past decade, Medical Ikkou Group Co's PS Ratio has ranged from 0.16 to 1.03. According to the industry distribution chart, Medical Ikkou Group Co ranks #67 out of 551 companies in the Conglomerates industry, placing it in the top 12.2%.
Is Medical Ikkou Group Co's PS Ratio too high?
Medical Ikkou Group Co's current PS Ratio of 0.19 is 42% below median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 1.03. The Conglomerates industry median PS Ratio is 0.92. Medical Ikkou Group Co's value of 0.19 is 79.3% below this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #67 out of 551 companies in the Conglomerates industry, which is in the top quartile — a strong position relative to peers. Overall, Medical Ikkou Group Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's PS Ratio compare to HON and MMM?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #67 out of 551 companies for PS Ratio. This places Medical Ikkou Group Co in the top 12% of its industry — outperforming the majority of peers. The industry median PS Ratio is 0.92. Medical Ikkou Group Co's value of 0.19 is 79.3% below this benchmark. Historically, Medical Ikkou Group Co's own PS Ratio has ranged from 0.16 to 1.03 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 0.92, Medical Ikkou Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Conglomerates company?
The median PS Ratio among Conglomerates companies is 0.92, based on 551 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current PS Ratio of 0.19 is 79.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median PS Ratio is 0.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current PS Ratio is 0.19, which is 42% below median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,535.59, compared to a current price of 円2,816.00 — trading 20.4% below its estimated fair value. The current PS Ratio is 0.19, which is 42% below median its 10-year median of 0.33 and 79.3% below the Conglomerates industry median of 0.92. Medical Ikkou Group Co's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current PS Ratio is 0.19 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,816.00 is trading 20.4% below its estimated GF Value™ of 円3,535.59.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
PS Ratio: 0.19 (42% below median its 10-year median of 0.33)
GF Value™: 円3,535.59 vs. price of 円2,816.00 (20.4% below fair value)
Industry Position: 79.3% below the Conglomerates median (#67 of 551)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
63GF Score
Get the complete analysis for TSE:3353
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
